Skip to Main Content

After years of controversy, Teva Pharmaceuticals (TEVA) agreed to pay $925,000 to the state of Mississippi to settle allegations of conspiring to set prices of generic medicines, the first instance in which a state and drug maker have reached a deal over sweeping price-fixing litigation.  Several current and former executives also reached a settlement, according to a court document.

In 2019, Mississippi was one of 43 states that accused more than a dozen generic drug makers and some of their executives of participating in a long-running conspiracy that, ultimately, raised prices for an untold number of Americans. The lawsuit was actually an expanded version of litigation filed in 2016 and the alleged conspiracies were also the focus of a third lawsuit filed last year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment